Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04346992
Other study ID # R109
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 12, 2020
Est. completion date March 15, 2022

Study information

Verified date September 2022
Source Fayoum University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Hormonal imbalances are likely to affect the corneal metabolism and may be also associated with Keratoconus. Among the various endocrinologic dysfunctions assumed so far, thyroid gland dysfunction (TGD) (hypo- or hyperthyroidism; comprised as TGD) is frequently associated with eye diseases such as Graves disease


Description:

Aim of the work We aim to examine the prevalence of KC among patients already diagnosed by endocrinologist with TGD. Materials and methods Our Screening for KC will include evaluation of the demographic data and complete ophthalmological examination of the patients using: VA Refraction K reading Slit lamp examination Pentacam Study design Epidemiological study Inclusion citeria All patients diagnosed as thyroid gland dysfunction Control group Exclusion criteria Uncooperative patients


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date March 15, 2022
Est. primary completion date March 15, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - All patients diagnosed as thyroid gland dysfunction Exclusion Criteria: - Uncooperative patients

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no intervention
no intervention

Locations

Country Name City State
Egypt Fayoum University Fayoum

Sponsors (1)

Lead Sponsor Collaborator
Fayoum University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary prevalence of keratoconus in thyroid gland dysfunction Our Screening for KC will include evaluation of the demographic data and complete ophthalmological examination of the patients using:
VA Refraction K reading Slit lamp examination Pentacam
we will recruit patients who meer the inclusion criteria during the study period April-August 2020